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Adult stem cells maintain tissue homeostasis by their ability to both self-renew and differentiate to distinct cell
types. Multiple signaling pathways have been shown to play essential roles as extrinsic cues in maintaining adult
stem cell identity and activity. Recent studies also show dynamic regulation by epigenetic mechanisms as intrinsic
factors in multiple adult stem cell lineages. Emerging evidence demonstrates intimate crosstalk between these two
mechanisms. Misregulation of adult stem cell activity could lead to tumorigenesis, and it has been proposed that
cancer stem cells may be responsible for tumor growth and metastasis. However, it is unclear whether cancer stem
cells share commonalities with normal adult stem cells. In this review, we will focus on recent discoveries of
epigenetic regulation in multiple adult stem cell lineages. We will also discuss how epigenetic mechanisms regulate
cancer stem cell activity and probe the common and different features between cancer stem cells and normal
adult stem cells.
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Cancer stem cellIntroduction
Adult stem cells are defined as cells that have two cen-
tral properties: self-renewal and differentiation. Many
types of adult stem cells have the remarkable ability to
undergo asymmetric mitotic divisions that produce two
distinct daughter cells. Alternatively, they undergo sym-
metric divisions in a stochastic manner to produce more
stem cells and differentiating cells. One daughter main-
tains the stem cell properties, while the other differenti-
ates to replenish specialized cell types. The ability of
adult stem cell derivatives to divide and differentiate to
replace damaged tissues provides the body with an in-
ternal repair system.
Previous studies on adult stem cells have focused on
understanding how extrinsic signaling pathways regulate
proper stem cell functions. In addition, recent evidence
shows that intrinsic factors, such as chromatin structure
of stem cells, play important roles in regulating stem cell
identity and activity. Epigenetic mechanisms alter the
chromatin state of genes without altering their primary
DNA sequences. Three major epigenetic mechanisms* Correspondence: ltarayr1@jhu.edu; xchen32@jhu.edu
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sitioning driven by chromatin remodeling factors, DNA
methylation, and post-translational modifications of his-
tones, including methylation, phosphorylation, acetyl-
ation, ubiquitination, and sumoylation [1]. Together,
these mechanisms may establish a distinct epigenetic
state that leads to a unique gene expression pattern in
stem cells [2]. Perturbations of these epigenetic mecha-
nisms may lead to premature differentiation or continu-
ous self-renewal/proliferation of stem cells, a hallmark
of cancer.
The relationship between carcinogenesis and changes
in specific gene expression or genome stability has been
well documented [3-6]. Two major epigenetic mecha-
nisms, DNA methylation and post-translational modifi-
cations of histones, have been shown to contribute to
the initiation and progression of cancers [7-11]. Accu-
mulation of aberrant genetic mutations or abnormal epi-
genetic profiles could lead to tumor initiation in adult
stem cell lineages [12-14]. For example, using the
lineage-tracing method, studies in mice have shown that
aged intestinal stem cells (ISCs) accumulate cancer-
causing mutations [13,15]. However, while most studies
characterize epigenetic alterations in cancers usingentral Ltd. This is an open access article distributed under the terms of the
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display a wide degree of heterogeneity, and not all of
them have the ability to initiate and sustain a tumor
[16,17]. Recently, it has been proposed that a small
population of cancer cells, termed cancer stem cells
(CSCs), is distinct from other tumor cells and has the
capacity to drive tumor initiation and growth. By defin-
ition, CSCs are a subset of tumor cells that have the cap-
acity to self-renew, the potential to develop into any
other cells in the tumor, and the proliferative ability to
drive continued tumor expansion [18]. In the past dec-
ade, CSCs were found to exist in a wide range of solid
tumors [19-24]. CSCs are currently being targeted in
cancer treatments; however, they are relatively resistant
to a variety of chemo- and radiotherapy [25]. Therefore,
a better understanding of the biology of CSCs, including
epigenetic alterations that affect their function, is essen-
tial for developing effective cancer therapies. On the
other hand, the existence of CSCs raises the concern
that conclusions based on studies using entire tumors
might not apply to CSCs.
In this review, we will start by discussing the most re-
cent discoveries in epigenetic regulation of normal adult
stem cell lineages in multiple stem cell systems and
across several different model organisms. We will then
take up the question of epigenetic regulation in cancers,
focusing on recent data on CSCs and making compari-
sons with adult stem cells.
Epigenetic regulation in germline stem cells (GSCs)
Germ cells are a unique cell type because they are able
to generate an entire organism upon fertilization [26].
Because germ cells are responsible for initiating the next
generations, it is crucial that they retain accurate genetic
and epigenetic information and properly transmit such
information across generations [27]. In many organisms,
GSCs initiate a tightly controlled cellular differentiation
process called gametogenesis to produce gametes. Like
other adult stem cells, GSCs are capable of both self-
renewal and differentiation. In addition to extensive
knowledge about the role of extrinsic signaling pathways
in maintaining GSCs [28], recent studies have shown
that epigenetic mechanisms control the decision of GSC
self-renewal versus differentiation [29,30].
Histone modifications play an essential role in intrin-
sically regulating GSC identity and activity. Recent stud-
ies have identified a cohort of enzymes called “epigenetic
writers” and “epigenetic erasers” that generate or remove
a particular histone modification [31,32]. These enzymes
are shown to be important for stem cell activities. For
example, members of the ASH-2 complex in C. elegans
act as “epigenetic writers” to generate the active
trimethylation of histone H3 lysine 4 (H3K4me3). Defi-
ciencies in members of the ASH-2 complex, such asWDR-5 and H3K4 methyltransferase (HMT) SET-2, lead
to misregulation of a subset of genes required for worm
longevity [33]. Presence of an intact germline was neces-
sary for lifespan regulation by members of the ASH-2
complex, suggesting that the “epigenetic landscape” of
germ cells regulates somatic cell fitness. Additionally,
mutations in wdr-5, whose function is required for
ASH-2 complex stability and activity, lead to decreased
GSCs and improper gametogenesis, suggesting another
role for H3K4 methylation in maintaining GSC identity
and proper differentiation [34] (Figure 1A).
HMTs are also required for gametogenesis in Drosoph-
ila melanogaster. The Drosophila male and female GSC
lineages are both paradigmatic systems to study adult
stem cells in their physiological environment, or niche
[35-40]. In females, 2–3 GSCs reside in the germarium
located at the tip of each ovariole [41], and each ovary
contains about 16 ovarioles. Within the female GSC
niche, GSCs directly associate with somatic cells (i.e.,
cap cells, terminal filaments, and escort cells, Figure 1B).
GSCs mutant for eggless (egg), a HMT that generates the
repressive H3K9me3 modification, display both mainten-
ance and differentiation defects [36]. Removal of egg
function from germ cells using FLP-mediated FRT re-
combination leads to GSC maintenance defects in the
niche, suggesting that Egg is required intrinsically for
GSC self-renewal. Loss of egg in GSCs leads to decreased
expression of bone morphogenetic protein (BMP) path-
way components, which are necessary and sufficient for
GSC self-renewal. Consistent with the results observed
using loss-of-function alleles, knockdown of egg using an
RNAi transgene leads to GSC loss [36]. However, using
another RNAi transgene leads to enlarged germaria due
to the accumulation of GSC-like cells, suggesting an in-
trinsic role for egg in regulating GSC differentiation
[36,42]. It is rare for a single gene to be required for
both GSC maintenance and differentiation. The contra-
dictory results could stem from one or both of the RNAi
transgenes used having off targets. Interestingly, loss of
egg in escort cells in the female GSC niche leads to
germaria accumulating GSC-like cells, indicating that
Egg is also required non-cell-autonomously for proper
differentiation of GSCs. Most of the GSC-like cells away
from the niche still express high levels of BMP pathway
components, suggesting that Egg acts in escort cells to
prevent ectopic BMP signaling and allow proper GSC
differentiation. It is remarkable that Egg regulates both
GSC self-renewal and differentiation by having an op-
posite effect on the same signaling pathway in a cell
type-specific manner [36].
Another H3K9 methyltransferase in Drosophila, dG9a,
is required for the formation of functional spectrosome,
an organelle required for asymmetric divisions of female
GSCs. As a result of spectrosomal dysfunction, germaria
Figure 1 Illustrations of the GSC niches in C. elegans, male and female Drosophila and mouse. (A) C. elegans GSC niche. Illustration shows
the distal tip cell which acts as a niche to maintain GSCs. Dark red GSCs are within the influence of the niche and are maintained as GSCs. The
lighter GSCs are outside the influence of the niche which causes them to differentiate. (A’) Summary of epigenetic factors that regulate the C.
elegans GSC niche. (B) Drosophila female GSC niche. Illustration shows tip of the germarium with GSCs (dark pink, average 2-3) in the niche
comprised of terminal filaments and cap cells (dark green). Escort cells are shown in light green. GSC progenies are shown in light pink. (B’)
Summary of epigenetic factors that regulate the Drosophila female GSC niche. (C) Drosophila male GSC niche. Illustration shows tip of the testis
with GSCs (dark blue, average 9-12; only 2 are shown here) in the niche comprised of hub cells and CySCs (dark green). Cyst cells are shown in
light green. GSC progenies are shown in light blue. Round orange structures represent spectrosomes, and branched orange structures represent
fusomes. (C’) Summary of epigenetic factors that regulate the Drosophila male GSC niche. (D) Mouse GSC niche. Illustration shows Sertoli cells
which function as a niche to maintain GSCs. Myeloid cells and the basal membrane function as support cells to the niche. GSCs (dark red)
differentiate to form spermatogonia (light red) which further differentiate to spermatocytes (pink). (D’) Summary of epigenetic factors that
regulate the mouse GSC niche.
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cysts that fail to specify the oocyte for oogenesis [35].
“Epigenetic erasers” reverse particular histone modifica-
tions, which have been shown to regulate adult stem cell
maintenance [39,40]. For example, histone demethylases
remove methyl groups from methylated lysine residues of
histones [43]. The lysine-specific demethylase 1 (Lsd1),
which demethylates histone 3 on both lysine 4 and lysine 9(H3K4/K9), was shown to function in the ovary to prevent
GSC tumor formation and maintain proper egg chamber
development [39].
In Drosophila testis, a group of 8–12 GSCs reside in a
niche comprised of two types of somatic cells: hub cell
and cyst stem cells (CySCs) (Figure 1C). GSCs undergo
asymmetric cell divisions to ensure the balance between
self-renewal and differentiation [44]. Recent studies from
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ically, during GSC asymmetric divisions, preexisting his-
tone 3 (H3) is preferentially retained in the GSC, while
newly synthesized H3 is enriched in the other daughter
cell called a gonialblast (GB) committed for differenti-
ation. We further demonstrate that both asymmetric H3
segregation during GSC mitosis and post-mitotic rapid
turnover of preexisting H3 in GB contribute to this
asymmetric H3 distribution. Such asymmetric inherit-
ance of H3 could be a mechanism for the ability of GSC
to maintain its unique gene expression profile, as well as
allowing GB to reset its chromatin structure for differen-
tiation [45,46]. Interestingly, such an asymmetric H3 dis-
tribution pattern is abolished in testicular tumor in
which GSCs are overproliferative [45], suggesting that
this asymmetric H3 inheritance is related to different
cell fates from asymmetric cell divisions. It will be inter-
esting to investigate whether other stem cells use similar
mechanisms for a reliable epigenetic inheritance.
Recently, several proteins that generate, recognize, or
remove specific histone modifications have been re-
ported to play essential roles in male GSC maintenance.
For example, an “epigenetic reader” encoded by the
PHD finger protein 7 (PHF7) gene recognizes and associ-
ates with the active H3K4me2 mark. PHF7 is highly
expressed in early germ cells and is required for GSC
maintenance and spermatogonial differentiation [37]. An
“epigenetic eraser”, Drosophila Ubiquitously transcribed
tetratricopeptide repeat gene on the X chromosome
(dUTX), is the sole enzyme that demethylates the re-
pressive H3K27me3 mark [47]. Our group found that
dUTX regulates testis niche architecture by targeting the
Janus kinase signal transducer and activator of transcrip-
tion (JAK-STAT) signaling pathway, a major pathway re-
quired for GSC maintenance [40]. We further showed
that dUTX maintains active transcription of an inhibitor
of the JAK-STAT pathway encoded by Suppressor of
cytokine signaling at 36E (Socs36E) gene. Specifically,
dUTX removes the repressive H3K27me3 mark near the
transcription start site (TSS) of Socs36E gene. In
addition to its role in maintaining niche architecture,
dUTX also functions intrinsically in male GSCs to main-
tain their adhesion to hub cells by regulating the tran-
scription of DE-Cadherin [40]. Interestingly, mammalian
UTX, also known as KDM6A, has been shown to regu-
late reprogramming: Utx mutant somatic cells cannot be
induced to the ground state of pluripotency [48]. In
addition, mutations in the human homolog of UTX
cause an increase in H3K27me3 levels and lead to hu-
man cancers [49]. These observations suggest that UTX
H3K27me3 demethylase maintains stem cell properties
in multiple stem cell systems in different species.
Apart from histone modifying enzymes, dynamic regu-
lation by chromatin remodeling factors is also requiredto maintain GSC activity and identity. Chromatin re-
modeling enzymes use ATP hydrolysis to alter histone-
DNA contacts [50]. In Drosophila, nine ATP-dependent
remodelers have been classified into four families based
on their structural similarities: (1) imitation switch
(ISWI) family members which all have a SANT domain,
(2) SWI2/SNF2-related proteins which share a bromo-
domain, (3) CHD family members which all have a
chromodomain, and (4) Rad16 family members which
possess a ring finger [51]. Interestingly, ISWI maintains
GSCs in both males and females, suggesting a common
epigenetic mechanism in both sexes [52,53]. ISWI and
Nurf301 are two of the four subunits that form the nu-
cleosome remodeling factor (NURF) complex. In male
flies, mutations in either iswi or nurf301 lead to de-
creased GSCs [52]. In females mutant for either iswi or a
second ATP-dependent remodeling factor known as
Domino (DOM), GSCs are lost as a result of premature
differentiation [53]. In both sexes, the premature differ-
entiation of GSCs is caused by precocious expression of
the bag of marbles (bam) gene, which is necessary and
sufficient for GSC differentiation.
The role of chromatin remodeling factors in maintaining
GSC activity is also evident in mammals. In mice, Sertoli
cells maintain physical contact with germ cells throughout
gametogenesis (Figure 1D). They direct formation of the
stem cell niche by coordinating the functions of other sup-
port cell populations [54]. SIN3A, a nuclear corepressor
that associates with histone deacetylase-1 (HDAC1), is
highly expressed in Sertoli cells. HDACs remove acetyl
groups from specific lysine residues on histone tails, and
their activity is often associated with transcriptional re-
pression. Testes from mice lacking Sin3a exhibit a wide
range of defects from loss of GSCs and proliferative
spermatogonia to failure of spermatid differentiation. GSC
markers, such as Oct4 and Lin28, are downregulated in
Sin3a mutant testes [55,56], suggesting that the chromatin
structure of Sertoli cells is essential for maintaining active
transcription of key regulators for GSC maintenance
[55,56], probably through signaling pathways.
Epigenetic regulation in intestinal stem cells (ISCs)
The Drosophila midgut is the primary organ for food di-
gestion and nutrient absorption. Therefore, its mainten-
ance is essential for organismal growth and survival. The
midgut in Drosophila comprises an epithelial monolayer
that is surrounded by two layers of visceral muscle. Un-
like GSCs, ISCs could not be easily identified based on
their anatomic locations within the tissue. However, the
lineage-tracing technique was utilized to successfully
determine that ISCs reside at the basal side, adjacent to
the basement membrane of midgut [57,58]. ISCs are
multipotent in that they divide asymmetrically to self-
renew and give rise to progenitor cells called enteroblasts
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ate to EBs, while activated Wnt signaling leads to ectopic
ISC self-renewal [59,60]. EBs further differentiate into two
cell types: absorptive enterocytes (ECs) and entero-
endocrine cells (ees) [57,58] (Figure 2). While many stud-
ies on ISCs have focused on signaling pathways, such as
Notch and Wnt signaling pathways [61], recent studies
have uncovered important roles of epigenetic mechanisms
in maintaining ISC identity and activity.
Several histone-modifying enzymes have been impli-
cated in maintaining ISCs. One example is the Scrawny
(Scny) enzyme that deubiquitinates mono-ubiquitinated
H2B and functions in gene silencing. Adult flies mutant
for scny rapidly lose ISCs due to inappropriate activation
of the Notch pathway, which leads to ISC differentiation.
Furthermore, scny mutant flies have decreased GSCs in
testes and ovaries, as well as ISCs, suggesting that a sin-
gle histone- modifying enzyme is required in multiple
stem cell systems [62]. Interestingly, cells mutant for
scny have elevated ub-H2B and H3K4me3 signals, which
probably leads to more open chromatin and active tran-
scription of Notch target genes [62]. Consistent with the
requirement of ub-H2B for cellular differentiation, in fe-
male GSC lineage, ub-H2B signal is undetectable in
GSCs, but detectable in the cystoblasts (CBs), the imme-
diate daughter cells of GSCs committed for differenti-
ation [63]. Recently, a histone acetyltransferase (HAT)
encoded by the Atac2 gene has been shown to regulate
the activity of ISCs [64]. HATs transfer acetyl groups to
specific lysine residues on histone tails, a modification
that is mostly associated with active transcription. Atac2
is a component of the Ada-Two-A-containing (ATAC)
complex, which acetylates K16 on H4 [65,66]. Loss of
Atac2 leads to increased ISCs, whereas overexpression
of Atac2 promotes ISC differentiation [64]. The molecu-
lar mechanism by which Atac2 regulates ISC differenti-
ation remains unknown, but one possibility is that Atac2
activates Notch target genes by generating the H4K16ac
mark at their promoter regions.
In addition to histone-modifying enzymes, dynamic
regulation of ISC activities is achieved by DNA modifica-
tions. DNA methylation at cytosines is usually associatedFigure 2 Illustration of the ISC niche in Drosophila. (A) Drosophila ISC
membrane. Another daughter cell of ISC is an EB cell (blue), which further
epigenetic factors that regulate the Drosophila ISC niche.with repressive gene expression (reviewed in [2]). Mam-
malian methyl-CpG-binding protein-2 (MeCP2) recog-
nizes methylated DNA and associates with SIN3A and
HDAC1 histone-modifying enzymes, acting as a bridging
factor between DNA methylation and histone modifica-
tions [67]. Unlike mammals, DNA methylation is only de-
tectable in the early stages of Drosophila embryos [68].
Interestingly, expression of human MeCP2 (hMeCP2) in
Drosophila ECs in midgut alters the cytological distribu-
tion of heterochromatin protein-1 (HP-1), as determined
by immunofluorescence, and stimulates ISC proliferation.
These observations suggest that hMeCP2 misregulates
genes important for ISC maintenance [69].
Epigenetic regulation in hair follicle stem cells
In mammals, the stem cells within the hair follicle niche
(HF-SCs) are required to sustain hair regeneration and
pigmentation in a cyclical manner. HF-SCs refer to both
epithelial hair follicle stem cells and melanocyte (i.e.,
pigment) stem cells, both of which reside at the base of
the noncycling hair follicle in the bulge area (Figure 3).
Two hallmarks of HF-SCs are their extended state of
dormancy and slow cycling, properties which predispose
these cells to accumulate genetic mutations and epigen-
etic aberrations that lead to tumor formation [70].
Remarkably, the proliferation and differentiation cycle of
melanocytes is synchronized to the cycle of hair follicle
cells in order to regenerate pigmented hair [71]. Hair
follicles periodically undergo hair growth (anagen)
followed by destruction (catagen) and rest (telogen),
during which both stem cell populations remain quies-
cent for weeks in adulthood.
Several signaling pathways, including Wnt, BMP/TGF-β
and mitogen-activated phosphokinase (MAPK) pathways,
have been reported to play essential roles in activating
both stem cell populations coordinately [72-74] in order
to start a new cycle of hair follicle generation. Recent
reports have uncovered key roles of specific histone-
modifying enzymes in regulating the balance between
quiescence and activation of HF-SCs. For example,
Polycomb group (PcG) proteins, which are comprised of
Polycomb repressive complex 1 (PRC1) and PRC2, havelineage. Illustration shows an ISC (red) located at the basement
differentiates to EC (green) and ee (purple). (A’) Summary of
Figure 3 Illustration of the mammalian HF-SC niche. (A) Mammalian hair follicle and part of epidermis. Hair follicle stem cells or bulge stem
cells reside in the bulge. (A’) Summary of epigenetic factors that regulate the HF-SC niche.
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regeneration. Using chromatin immunoprecipitation, fol-
lowed by ChIP-seq, a high-throughput sequencing tech-
nique, chromatin changes upon transition from HF-SCs to
transit-amplifying progenies (HF-TA) have been character-
ized. In HF-SCs, PcG represses hair follicle differentiation
by generating the repressive H3K27me3 mark at TSSs of
key differentiation genes, which are repressed in HF-SCs,
but expressed in HF-TAs. Reciprocally, genes required for
HF-SC maintenance acquire high levels of H3K27me3 in
HF-TA cells, which was found to be necessary for proper
HF-TA differentiation [75]. Because PRC2 components
Enhancer of Zeste homolog 1 (Ezh1) and Ezh2 encode
H3K27me3 methyltransferases in mice, Ezh1/2 double
knockout HF-SCs have reduced H3K27me3 levels and de-
creased proliferation. Real-time PCR (RT-PCR) and im-
munofluorescence analyses in mutant HF-SCs revealed
increased transcription of the Ink4b/Ink4a/Arf gene locus,
which encodes cell cycle inhibitors p16, p15 and p19 [76].
Increased expression of cell cycle inhibitors may lead to
HF-SC proliferation defects.
Another recent study reported the role of Jarid2
in maintaining HF-SCs. Jarid2 is a member of the
JumonjiC (JmjC) domain-containing family of proteins.
Using ChIP, followed by quantitative PCR (qPCR) in
Jarid2 conditional knockout (cKO) neonatal keratino-
cytes, H3K27me3 was demonstrated to have reduced
levels at PRC2 target genes, suggesting that Jarid2 re-
cruits PRC2 to their targets. These data are consistent
with the function of Jarid2 in embryonic stem cells
(ESCs) [77,78]. Although Jarid2 has been found to be
dispensable for HF-SC establishment and maintenance,
in Jarid2 cKO mice, loss of Jarid2 leads to increased ex-
pression of p16, which results in reduced proliferation
and delayed hair follicle cycling of HF-SCs [79].Abnormal epigenetic regulation in cancers
Self-renewal and proliferative abilities are essential for
maintaining stem cell number and preventing tissue dys-
trophy. However, several mechanisms are required to
tightly regulate stem cell self-renewal and proliferation
in order to prevent uncontrolled cell expansion and
tumor generation. The cancer stem cell (CSC) model
proposes that a subpopulation of tumor cells self-renew
and give rise to more differentiated cells that form the
tumor [19-24,80]. CSCs are highly proliferative and re-
sponsible for sustained tumor growth, as well as new
tumor formation upon metastasis [81]. Therefore, un-
derstanding the cellular and molecular characteristics of
CSCs may have many implications for developing thera-
peutic strategies against cancers.
Several epigenetic mechanisms have been implicated
in maintaining the identity and activity of CSCs (Table 1).
For example, global DNA hypomethylation has been
shown to be a hallmark of many benign and invasive tu-
mors [82-84]. S100A4, a metastasis-associated gene, has
been found to be hypomethylated in colon cancer [85],
and hypomethylation at the oncogene R-RAS region is
associated with gastric cancer [86]. DNA demethylation
is a recently identified phenomenon with the discovery
of the ten-eleven-translocation (TET) family genes.
Members of the Tet family of proteins (Tet1/2/3) are
dioxygenases that convert cytosine-5-methylation (5mC)
to 5-hydroxymethyl-cytosine (5hmC) [87,88], the re-
moval of which contributes to the DNA demethylation
process [89]. Interestingly, levels of 5hmC are substan-
tially reduced in a number of human cancers, including
breast, liver, lung and pancreatic cancers, which was found
to be associated with dramatically reduced expression of
all three TET genes [90]. It is very likely that abnormal epi-
genetic regulation at TET genes’ loci leads to their reduced
Table 1 Summary of epigenetic factors that regulate CSCs
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human melanomas, and, interestingly, introduction of ac-
tive TET2 suppresses melanoma growth [91].
On the other hand, genetic mutations in TET genes
have been found in other cancers, including leukemia
and lymphoma [91-94], suggesting an essential role of
DNA demethylation in carcinogenesis. Specifically, TET2
has been shown to act as a critical tumor suppressor
and is frequently mutated in leukemia and myeloid can-
cers [95,96]. TET1 has also been shown to be a tumor
suppressor in various cancers, including prostate and
breast cancers [97,98]. Interestingly, while TET genes are
frequently downregulated in tumors, a recent study
reported that TET1 is upregulated in MLL-rearranged
leukemia which is accompanied by a global increase in
5hmC levels, suggesting a role for TET1 as an oncogene
instead of a tumor suppressor. Such an observation
highlights the importance of tissue context in under-
standing a gene’s function since TET1 can act as a tumor
suppressor in solid tumors, but as an oncogene in
leukemogenesis. Furthermore, while both Tet1 and Tet2
have similar catalytic activities, they play opposing
pathological roles in leukemogenesis, probably due to
different target genes.
On the other hand, increased DNA methylation has
been detected at promoters of tumor suppressor genes,
such as p16 in melanoma [99], RB1 in retinoblastoma
[100], and RUNX3 in human brain tumors [101]. Hyper-
methylation was also detected at the promoter region of
Caspase 8 associated protein 2 (CASP8AP2) gene in
acute lymphoblastic leukemia [102]. DNA methylation is
generated by DNA methyltransferase 1 (DNMT1) and
maintained by DNMT3A and DNMT3B in humans
[103-105]. DNA methylation has been shown to regulate
CSC activity and tumor growth. For example, cKO of
Dnmt1 in mice with leukemia blocks further develop-
ment of pre-existing leukemia. Furthermore, halving the
level of Dnmt1 in wild-type mice leads to impairedleukemia stem cell self-renewal and survival, probably
from hypomethylation and derepression of a number of
tumor suppressor genes. Interestingly, using ChIP with
H3K27me3 antibodies, the authors found that EZH2-
controlled target genes are also derepressed in Dnmt1
haploinsufficient mice. These data suggest that the PcG
complexes might cooperate with DNA methylation to regu-
late leukemia stem cell activity and tumor growth [106].
Consistent with the role of PcG in deterring tumor
development, upregulation of EZH2 leads to aggressive
progression of both breast and prostate cancers [107,108].
A recent study reported that a high level of EZH2 expres-
sion leads to expansion of breast CSCs. Upregulation of
EZH2 may lead to repression of the RAD51 gene, which is
known for DNA double-strand break repair. Failure in
DNA repair results in increased genome instability and
tumor progression [109]. Furthermore, pharmacological
inhibition of PRC2 components, including EZH2, reduces
expression of CSC markers and decreases tumor forma-
tion and growth in multiple types of cancers [110-112].
Furthermore, knockdown of the oncogene BMI1 reduces
expression of glioma stem cell genes and inhibits glioblast-
oma formation in vivo [113]. BMI1 is a component of
Polycomb repressive complex 1 (PRC1), which inhibits ex-
pression of tumor suppressor proteins p16 and p14. Glio-
blastoma multiforme (GBM) is one the most common
and lethal types of adult brain tumors [114]. Conditions
such as hypoxia enhance the expression of glioma stem
cell genes. Both hypoxia-inducible factor-1α (HIF1α) and
HIF2α are preferentially expressed in glioma stem cells
and are required for their maintenance [115-117]. Interest-
ingly, knockdown of mixed-lineage leukemia 1 (MLL1), an
H3K4me3 methyltransferase, inhibits expression of HIF2α
and reduces glioma stem cell self-renewal and growth
[118]. These data suggest that epigenetic regulation of
CSCs directly controls cancer initiation and growth.
Histone demethylases have also been reported to regulate
tumor formation and survival. For example, LSD1, which
suppresses gene expression by converting dimethylated
H3K4 to monomethylated and unmethylated H3K4, was
shown to be highly expressed in pluripotent tumors.
Pluripotent tumor cells express pluripotent stem cell
markers, such as Oct4 and Sox2, and have the ability to
differentiate into many cell types [119-122]. Knockdown
of Lsd1 leads to growth inhibition of pluripotent tumor
cells, such as in teratocarcinoma, embryonic carcinoma
and seminoma [123].
Conclusions
In this review, we discussed recent advances in our
understanding of epigenetic mechanisms in normal adult
stem cell lineages and in tumorigenesis. Several epigen-
etic mechanisms have been shown to play important
roles, including DNA methylation, covalent histone
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ies are needed to understand how different epigenetic
mechanisms coordinate to ensure normal cellular differ-
entiation in adult stem cell lineages and to prevent
cancers. To better understand cancers, researchers are
now focusing on the relationship between CSCs and
normal stem cells. While both stem cell types have the
ability to self-renew and differentiate, adult stem cells
require niche cells to maintain their “stemness”, whereas
no niche has been identified for any type of CSCs.
Additionally, while DNA methylation plays essential
roles in tumorigenesis and CSC regulation, little is
known about how DNA methylation regulates adult
stem cells [68]. Multiple epigenetic factors are now con-
sidered targets for therapeutic strategies against cancer,
and more studies are needed to elucidate the roles of
epigenetic factors in tumor metastasis.
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